Lastly, the drug sensitivity data from Genomics of Drug Sensitivity in Cancer (GDSC, version 17.3) showed osteosarcoma cell lines with various response to CDK6 or EGFR inhibitors (Figure S4). Here, CDK6 is linked to osteosarcoma.